ResearcherThe University of Texas Rio Grande ValleyActive in the last 2 years

Tushar Deb Nath

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0849-3757; OpenAlex author ID A5051042736. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2026: 1 paper

Papers 1

Targeted Therapy in Hepatobiliary Pancreatic Cancer (HPC): Advantages and Advancements of Antibody Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs. Co-author DOI 10.3390/ijms27062707 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Debasish Bandyopadhyay · 1 shared paper, 2026 · strength 0.43
- Paper Targeted Therapy in Hepatobiliary Pancreatic Cancer (HPC): Advantages and Advancements of Antibody Drug Conjugates, a T… DOI 10.3390/ijms27062707 ↗
Subhash C. Chauhan · 1 shared paper, 2026 · strength 0.43
- Paper Targeted Therapy in Hepatobiliary Pancreatic Cancer (HPC): Advantages and Advancements of Antibody Drug Conjugates, a T… DOI 10.3390/ijms27062707 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.